Literature DB >> 28267255

A systematic review examining quality of life following pelvic exenteration for locally advanced and recurrent rectal cancer.

E Rausa1,2, M E Kelly1, L Bonavina2, P R O'Connell1,3, D C Winter1,3.   

Abstract

AIM: Pelvic exenteration is a complex surgical procedure associated with considerable morbidity. Quality of life (QoL) is a crucial metric of surgical outcome. The aim of this review was to assess the QoL following pelvic exenteration for locally advanced rectal cancer (LARC) and local recurrent rectal cancer (LRRC).
METHOD: A comprehensive search of studies published between 2000 and 2016 that examined QoL outcome following pelvic exenteration was performed. Functional Assessment of Cancer Therapy - Colorectal (FACT-C), SF-36 version 2, European Organization for Research and Treatment of Cancer QLQ-C30, and Brief Pain Inventory assessments from these studies were reviewed.
RESULTS: Seven studies reporting on 382 patients were included. Baseline QoL was the strongest predictor of postoperative QoL. Female gender, total pelvic exenteration with or without bone resection, and positive surgical margins were associated with a reduced QoL. In the majority of patients, QoL gradually improved between 2 and 9 months post-operation.
CONCLUSION: QoL is an important patient-reported outcome. This review highlights factors associated with reduced postoperative QoL that should be borne in mind when surgical resection is being considered. Colorectal Disease
© 2017 The Association of Coloproctology of Great Britain and Ireland.

Entities:  

Keywords:  Rectal cancer; pelvic exenteration; quality of life; recurrent neoplasm; surgical outcomes

Mesh:

Year:  2017        PMID: 28267255     DOI: 10.1111/codi.13647

Source DB:  PubMed          Journal:  Colorectal Dis        ISSN: 1462-8910            Impact factor:   3.788


  6 in total

1.  State-of-the-art surgery for recurrent and locally advanced rectal cancers.

Authors:  Mufaddal Kazi; Vivek Sukumar; Ashwin Desouza; Avanish Saklani
Journal:  Langenbecks Arch Surg       Date:  2021-08-02       Impact factor: 3.445

2.  Exploring reasons behind patient compliance with nutrition supplements before pelvic exenteration surgery.

Authors:  Sophie E Hogan; Michael J Solomon; Sharon K Carey
Journal:  Support Care Cancer       Date:  2018-09-05       Impact factor: 3.603

Review 3.  The role of imaging in pelvic exenteration for gynecological cancers.

Authors:  Pamela Ines Causa Andrieu; Sungmin Woo; Eric Rios-Doria; Yukio Sonoda; Soleen Ghafoor
Journal:  Br J Radiol       Date:  2021-05-07       Impact factor: 3.629

Review 4.  Minimally Invasive Endoscopic and Surgical Management of Rectal Neoplasia.

Authors:  Sarah S Al Ghamdi; Ira Leeds; Sandy Fang; Saowanee Ngamruengphong
Journal:  Cancers (Basel)       Date:  2022-02-14       Impact factor: 6.639

5.  The choice of medical facility and associated factors among Chinese advanced colorectal cancer patients: a cross-sectional multi-center study.

Authors:  Xiao-Yang Wang; Wen-Jun Wang; Yu-Qian Zhao; Yin Liu; Xiao-Hui Wang; Ling-Bin Du; Shuang-Xia Duan; Xi Zhang; Yan-Qin Yu; Li Ma; Yun-Yong Liu; Juan-Xiu Huang; Ji Cao; Li Li; Xiao-Fen Gu; Yan-Ping Fan; Chang-Yan Feng; Xue-Mei Lian; Jing-Chang Du; Jian-Gong Zhang; You-Lin Qiao
Journal:  Ann Transl Med       Date:  2022-03

Review 6.  Surgical treatment of locally recurrent rectal cancer: a narrative review.

Authors:  Zhaoya Gao; Jin Gu
Journal:  Ann Transl Med       Date:  2021-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.